Jane Street Group, LLC Provention Bio, Inc. Put Options Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 15, 2022	SELL	$5.59 - $7.39 $150,930 - $199,530	-27,000 Reduced 32.85%	55,200 $310,000
Q3 2021 Nov 16, 2021	SELL	$5.66 - $8.33 $190,742 - $280,721	-33,700 Reduced 29.08%	82,200 $526,000
Q2 2021 Aug 16, 2021	BUY	$6.71 - $11.04 $700,524 - $1.15 Million	104,400 Added 907.83%	115,900 $977,000
Q2 2020 Aug 17, 2020	BUY	$7.81 - $17.0 $89,815 - $195,500	11,500 New	11,500 $162,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.